Bett, Andrew J.
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChatORCID 0000-0003-3490-7818
Most cited papers
- Verified
Packaging capacity and stability of human adenovirus type 5 vectors
Bett, A. J., Prevec, L., & Graham, F. L. (1993) · Journal of Virology
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 472
- Verified
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines
Respiratory viral infections researchSARS-CoV-2 and COVID-19 Research
Cited by 190
- Verified
Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine
Qureshi, H., Ma, Z.-M., Huang, Y., Hodge, G., Thomas, M. A., DiPasquale, J., DeSilva, V., Fritts, L., Bett, A. J., Casimiro, D. R., et al. (2012) · Journal of Virology
HIV Research and TreatmentSARS-CoV-2 and COVID-19 Research
Cited by 90
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free